Cerecor Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,421.50
11,800.70
21,220.80
5,139.10
2,474.10
10,665
Total Accounts Receivable
-
-
-
132.50
7,431.80
8,626.60
Inventories
-
-
-
-
382.20
1,110.80
Other Current Assets
714.30
360.30
401.60
391.30
703.20
1,529.50
Total Current Assets
4,135.80
12,161.00
21,622.30
5,662.80
10,991.40
21,931.90
Net Property, Plant & Equipment
66.00
38.70
35.20
43.20
44.60
586.50
Total Investments and Advances
175.00
117.20
-
62.80
131.40
81.70
Intangible Assets
-
-
-
-
31,956.80
47,650.60
Other Assets
698.90
-
-
-
-
-
Total Assets
5,075.60
12,316.90
21,657.60
5,768.90
43,124.10
70,342
ST Debt & Current Portion LT Debt
-
1,905.90
3,208.10
2,353.70
-
Accounts Payable
-
-
678.10
1,010.20
1,299.00
Income Tax Payable
-
-
-
-
2,259.10
Other Current Liabilities
3,065.60
3,087.90
1,963.60
948.00
7,848.30
Total Current Liabilities
3,065.60
4,993.80
5,849.80
4,311.90
11,406.40
Long-Term Debt
-
5,308.20
2,353.50
-
-
Deferred Taxes
-
-
-
-
7.10
Other Liabilities
-
-
370.50
1,250.00
3,850.90
Total Liabilities
3,065.60
10,302.00
8,573.80
5,561.90
15,264.50
Common Equity (Total)
17,846.70
26,330.70
13,083.70
207.00
27,859.60
Total Shareholders' Equity
2,010.00
2,014.90
13,083.70
207.00
27,859.60
Total Equity
2,010.00
2,014.90
13,083.70
207.00
27,859.60
Liabilities & Shareholders' Equity
5,075.60
12,316.90
21,657.60
5,768.90
43,124.10
Preferred Stock (Carrying Value)
19,856.60
28,345.50
-
-
-

About Cerecor

View Profile
Address
540 Gaither Road
Rockville Maryland 20850
United States
Employees -
Website http://www.cerecor.com
Updated 07/08/2019
Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406.